1. Home
  2. PACB vs MYN Comparison

PACB vs MYN Comparison

Compare PACB & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
    SELLHOLDBUYas of 9 hours ago
  • MYN
    SELLHOLDBUYas of 9 hours ago
  • Stock Information
  • Founded
  • PACB 2000
  • MYN 1992
  • Country
  • PACB United States
  • MYN United States
  • Employees
  • PACB N/A
  • MYN N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • MYN Finance Companies
  • Sector
  • PACB Industrials
  • MYN Finance
  • Exchange
  • PACB Nasdaq
  • MYN Nasdaq
  • Market Cap
  • PACB 364.2M
  • MYN 382.4M
  • IPO Year
  • PACB 2010
  • MYN N/A
  • Fundamental
  • Price
  • PACB $1.23
  • MYN $9.98
  • Analyst Decision
  • PACB Buy
  • MYN
  • Analyst Count
  • PACB 13
  • MYN 0
  • Target Price
  • PACB $2.46
  • MYN N/A
  • AVG Volume (30 Days)
  • PACB 8.3M
  • MYN 86.0K
  • Earning Date
  • PACB 05-08-2025
  • MYN 01-01-0001
  • Dividend Yield
  • PACB N/A
  • MYN 4.12%
  • EPS Growth
  • PACB N/A
  • MYN N/A
  • EPS
  • PACB N/A
  • MYN N/A
  • Revenue
  • PACB $154,014,000.00
  • MYN N/A
  • Revenue This Year
  • PACB $7.15
  • MYN N/A
  • Revenue Next Year
  • PACB $26.20
  • MYN N/A
  • P/E Ratio
  • PACB N/A
  • MYN N/A
  • Revenue Growth
  • PACB N/A
  • MYN N/A
  • 52 Week Low
  • PACB $1.08
  • MYN $8.47
  • 52 Week High
  • PACB $3.70
  • MYN $10.62
  • Technical
  • Relative Strength Index (RSI)
  • PACB 45.27
  • MYN 46.00
  • Support Level
  • PACB $1.08
  • MYN $9.80
  • Resistance Level
  • PACB $1.28
  • MYN $10.08
  • Average True Range (ATR)
  • PACB 0.09
  • MYN 0.10
  • MACD
  • PACB 0.01
  • MYN 0.01
  • Stochastic Oscillator
  • PACB 51.72
  • MYN 48.65

Stock Price Comparison Chart: PACB vs MYN

PACB
MYN
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0510152025303540PACB VS MYN

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock

Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use